The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Bevacizumab, etoposide, and cisplatin (BEEP) in brain metastases of breast cancer progressing from radiotherapy: Results of the first stage of a multicenter phase II study.
Yen-Shen Lu
No relevant relationships to disclose
Wei-Wu Chen
No relevant relationships to disclose
Ching-Hung Lin
No relevant relationships to disclose
Ling-Ming Tseng
No relevant relationships to disclose
Dah-Cherng Yeh
No relevant relationships to disclose
Pei-Fang Wu
No relevant relationships to disclose
Bang-Bin Chen
No relevant relationships to disclose
Ta-Chung Chao
No relevant relationships to disclose
Yi-Fang Tsai
No relevant relationships to disclose
Shu-Min Huang
No relevant relationships to disclose
Tiffany Ting-Fang Shih
No relevant relationships to disclose
Ann-Lii Cheng
No relevant relationships to disclose